| Filed On | Filing |
|---|---|
| 12 Nov 2026 |
Form 4: Tobin James R, Director
Received 41,666 shares by exercise or conversion ($2.35M) · Sold 41,666 shares ($3.13M) |
| 10 Nov 2026 | 144 |
| 05 Nov 2026 |
Form 4: Rhoads Ann D, Director
Sold 5,000 shares ($425K) |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition; Other Events
AUDUBON, PA., November 5, 2026: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the third quarter ended September 30, 2026. |
| 04 Nov 2026 | 144 |
| 30 Oct 2026 | SCHEDULE 13G/A |
| 27 Oct 2026 | SCHEDULE 13G/A |
| 16 Sep 2026 |
Form 4: Tobin James R, Director
Received 30,000 shares by exercise or conversion ($1.76M) · Sold 30,000 shares ($2.24M) |
| 15 Sep 2026 | 144 |
| 19 Aug 2026 |
Form 4: Zarrilli Stephen T, Director
Received 25,000 shares by exercise or conversion ($1.33M) · Sold 25,000 shares ($2.18M) |
| 18 Aug 2026 | 144 |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
AUDUBON, PA., August 6, 2026: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the second quarter ended June 30, 2026. |
| 28 Jul 2026 |
Form 4: Davidar David D, Director
Gave 2,500 shares as a gift |
| 09 Jun 2026 |
Form 4: Davidar David D, Director
Received 25,000 shares by exercise or conversion ($657K) · Sold 25,000 shares ($2.02M) |
| 08 Jun 2026 |
Form 4: Rhoads Ann D, Director
Received 25,000 shares by exercise or conversion ($657K) |
| 05 Jun 2026 | 144 |
| 04 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
The purpose of the Globus Medical, Inc. 2021 Equity Incentive Plan (as it may be amended or restated from time to time, the “Plan”) is to promote the success and enhance the value of Globus Medical, Inc. (the “Company”) by linking the in... |
| 27 May 2026 | SD |
Loading...